Skip to nav Skip to content

IDSA Media Briefing: AMR - The Next Crisis

Facebook Twitter LinkedIn Email

A media briefing with the Infectious Diseases Society of America to discuss the urgent need to combat drug-resistant infections.

Topical Agenda for June 30 Briefing:

  • Impact of COVID-19 on AMR progress
  • Challenges of antibiotic development
  • Plausible solutions and the promise of the PASTEUR Act
  • Perspectives from an AMR survivor
  • Questions from media

Vance Fowler, MD, MHS, FIDSA—Durham, NC
Chair—Antimicrobial Resistance Committee, Infectious Diseases Society of America
Professor of Medicine, Duke University School of Medicine
Florence McAlister Distinguished Professor of Medicine

Tori Kinamon—Durham, NC
MD Candidate, Duke University School of Medicine
FDA Antibacterial Drug Resistance (DOOR) Fellow
MRSA Survivor and NCAA Infection Prevention Advocate

Chris Busky, CAE (Moderator)
Chief Executive Officer—Infectious Diseases Society of America

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.